Efficacy of ultra-short-acting β-blocker on cardiac ischemia in patients with serious coronary lesions
10.3969/j. issn. 1008-0074. 2011. 03.12
- VernacularTitle:超短效β阻滞剂治疗严重冠脉病变患者心肌缺血疗效观察
- Author:
Haiyan QIAN
;
Ji HUANG
;
Yuejin YANG
;
Zhizhong LI
;
Jingmei ZHANG
- Publication Type:Journal Article
- Keywords:
Esmolol;
Coronary Artery Disease;
Angina;
Myocardial Infarction
- From:
Chinese Journal of cardiovascular Rehabilitation Medicine
2011;20(3):229-235
- CountryChina
- Language:English
-
Abstract:
Objective: To explore the efficacy of esmolol on cardiac ischemia in patients with serious coronary lesions who are not candidates for coronary revascularizations. Methods: Fifty seven aged patients (34 male) with serious coronary artery disease not candidates for coronary revascularizations were included. All patients had classical angina involved in cardiac ischemia, and definitely ischemic ST-segment depressions in surface electrocardiogram, however which were not relieved by routine treatment including intravenous nitrate or even morphine. All patients received loading dose injection and continuously intravenous infusion of Esmolol, and the baseline characteristics before treatment and the effects at 4 hours after infusion of Esmolol were carefully recorded. Results: After infusion of Esmolol, the ischemia-related symptoms of 41 patients completely relieved, and their ST depressions recovered to the baseline accompanied with significant reduction in blood pressure and heart rate (P＜0.0001 all) within (66±23) min. Moreover, nine patients were observed that their ischemia-related symptoms were relieved and ST alteration recovered partially (P＜0.0001 both) at four h after continuous infusion of esmolol. Conclusion: Esmolol is effective to relieve the serious cardiac ischemia-related symptoms and ST-T alteration of ECG in patients with serious coronary lesions.
- Full text:P020110630651451867307.doc
